You might be interested in
Health & Biotech
‘Moving ahead with vigour’: Rhythm raises $3.5m for 2025 cancer test launch
Health & Biotech
Health Check: Mayne Pharma and Acrux are on a drug expansion drive, generically speaking
Health & Biotech
Stockhead TV
Tony Locantro has been a client advisor/investment manager in the stockbroking industry since 1998. He’s focused on the small cap and emerging companies with a strong interest in identifying those in the mining, biotech and industrial sectors that offer growth potential.
He also delves into the psychology of speculation and provides regular insights on a number of social media and finance related outlets.
This week on Tony’s Takeaway, host Tony Locantro looks at two biotech stocks in Nyrada (ASX:NYR) and Radiopharm Theranostics (ASX:RAD) with exciting news in a sector presenting some outstanding opportunity.
The views, information, or opinions expressed in this video are solely those of the author and do not represent the views of Stockhead.
Stockhead has not provided, endorsed or otherwise assumed responsibility for any financial product advice contained in this article. Viewers should obtain independent advice based on their own circumstances before making any financial decisions.